Select Page

Company to buy

  • Size: small business
  • Revenue: 1 – 5 million EUR
  • Location of the target company: anywhere in Europe
  • Reason for acquisition: The buyer wants to invest its funds into a profitable company in the same industry in order to strengthen its market position on the European market
  • #CFIE PHB056

Overview of the buyer for a pharma services company in Europe

A pharma services company based in Europe has reached out to an advisor for help with an identification of a suitable pharma services company to acquire. The target should be financially healthy (not in a declining state) and have a positive EBITDA.

Profile (strategy) of this buyer for a pharma services company in Europe

The buyer is a well-established European company, specialized in servicing the pharmaceutical and life science sector. The company is a specialist in regulatory affairs and quality assurance services. The services portfolio is however much wider, including e.g.:

  • market access
  • clinical studies
  • pharmacovigilance
  • process & quality services
  • training
  • medical devices consulting
  • biocides and medical-surgical devices consulting etc.

The buyers consolidated revenue exceeds 20 million EUR, with an EBITDA margin higher than 20%. The company has reached out to an advisor for help with the help of identifying possible targets in European pharma services industry. The buyer company wants to expand as soon as possible, therefore they are ready to evaluate possible targets as soon as they will occur.

Subscribe as an interested seller
Contact us to get details about this buyer for a pharma services company in europe

Activities and products of the target pharma company

The buyer is looking for a target, which is providing services for the pharma industry. For example, the target can be involved in one of the following activities:

  • regulatory affairs
  • pharmacovigilance
  • manufacturing practice development
  • CRO

Regarding the financial situation – it would be good if the target company was profitable, but better if the company has low profit, as the valuation would be lower. The buyer is interested in a 100% acquisition or majority share acquisition with put and call option after 2-3 years.

Preferably the company should not own the real estate, but rather be in leased premises.

The buyer is expecting to accept valuations of up to 5 times EBITDA, the exact offer will, of course, depend on many variables, such as financial stability, and market position of the target. The buyer has the funds ready, the company can cover up to 2 million EUR out of its own funds.

Highlights of the pharma services company wanted in Europe

  • The buyer is a medium-sized company with an experienced management team and acquisition appetite
  • The buyer is respected in its field and is well known among the players in the local pharma industry
  • The buyer is looking for a company with 1 to 5 million EUR in turnover

More information on this buyer for a pharma services company in Europe

Please get in touch if you are interested in learning more about this buyer for a pharma services company in Europe. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.

Subscribe as a seller for this Pharma buyer

en_GBEnglish (UK)